Tag: HCPCS codes
Biosimilars are billed differently than generics under Medicare Part B. Each has its own HCPCS code and payment rate based on its ASP plus 6% of the reference product’s price. This system encourages biosimilar entry but doesn’t strongly incentivize switching. Learn how billing works and why adoption remains low in the U.S.
Archives
Recent-posts
Antibiotic Resistance: Understanding Why Your Medication Changes and New Treatment Choices
Apr, 26 2025

Medications